Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thrombolytic agents in critical care

B Weiner

    Critical Care Nursing Clinics of North America
    |June 1, 1993
    PubMed
    Summary

    Early thrombolytic therapy improves survival in critically ill patients. This treatment, part of hemostasis, uses plasmin to break down blood clots, decreasing mortality and enhancing patient outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Intervention strategies for microbial therapeutics in cancer immunotherapy.

    Immuno-oncology technology·2022
    Same author

    Characterization of biochars and dissolved organic matter phases obtained upon hydrothermal carbonization of Elodea nuttallii.

    Bioresource technology·2015
    Same author

    Organic breakdown products resulting from hydrothermal carbonization of brewer's spent grain.

    Chemosphere·2015
    Same author

    Hydrothermal carbonization of poly(vinyl chloride).

    Chemosphere·2014
    Same author

    Characterization of biocoals and dissolved organic matter phases obtained upon hydrothermal carbonization of brewer's spent grain.

    Bioresource technology·2014
    Same author

    Organic compounds in olive mill wastewater and in solutions resulting from hydrothermal carbonization of the wastewater.

    Chemosphere·2013

    Area of Science:

    • Cardiovascular Medicine
    • Hematology

    Background:

    • Hemostasis is the body's natural defense against fatal hemorrhage after vascular injury.
    • Thrombolysis, a key component of hemostasis, involves the breakdown of blood clots.
    • Plasmin is the primary protein mediating natural clot lysis.

    Purpose of the Study:

    • To highlight the critical role of early thrombolytic therapy in improving survival for critically ill patients.
    • To underscore the efficacy of intravenous thrombolytic agents in reducing mortality.
    • To demonstrate the positive impact on overall patient outcomes.

    Main Methods:

    • Review of recent studies on thrombolytic therapy.
    • Analysis of data concerning intravenous administration of thrombolytic agents.
    • Evaluation of patient survival and outcome metrics.

    Main Results:

    • Early and optimal dosage of thrombolytic therapy significantly improves survival rates.
    • Intravenous thrombolytic agents have demonstrated efficacy in decreasing patient mortality.
    • Improved patient outcomes are associated with timely thrombolytic interventions.

    Conclusions:

    • Thrombolytic therapy is a vital intervention for critically ill patients.
    • Intravenous administration of thrombolytic agents is effective in improving survival and patient outcomes.
    • The timely application of thrombolysis plays a crucial role in managing hemostasis and preventing fatal hemorrhage.

    Related Experiment Videos